This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Type 2 diabetes, strict (exclude DM1)
DOID EFO MESH SNOMED Endpoint Browser
E4_DM2_STRICT
type II diabetes mellitus: A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions
not E4_DM1
417843
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
A10B
1 out of 7 registries used, show all original rules.
62550
Check minimum number of events
Min. number of events
3
62550
Include endpoints
67550
Remove individuals based on genotype QC
65013
E4_DM2_STRICT
Control definitions
Control conditions
not E4_DM1
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Type 2 diabetes, strict (exclude DM1)
based on the number of shared cases.
Broader endpoints:
- Type 2 diabetes, definitions combined
- Type 2 diabetes, definitions combined, including avohilmo
- Type 2 diabetes
- Diabetes, varying definitions
- Diabetes mellitus
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 65013 | 28897 | 36116 |
| Unadjusted prevalence (%) | 15.78 | 12.55 | 19.87 |
| Mean age at first event (years) | 59.94 | 58.62 | 61.00 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_DM2_STRICT – Type 2 diabetes, strict (exclude DM1)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Type 2 diabetes, strict (exclude DM1)
↥Endpoint not on priority list, no data to show.